ITERUM THERAPEUTICS PLC (ITRM) Forecast, Price Target & Analyst Ratings

NASDAQ:ITRM • IE000TTOOBX0

Current stock price

0.0356 USD
-0.14 (-79.77%)
At close:
0.0929 USD
+0.06 (+160.96%)
Pre-Market:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ITERUM THERAPEUTICS PLC (ITRM).

Forecast Snapshot

Consensus Price Target

Price Target
$9.18
+ 25,686.52% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 11, 2026
Period
Q4 / 2025
EPS Estimate
-$0.15
Revenue Estimate
515.1K
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.50%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$9.18
Upside
+ 25,686.52%
From current price of $0.04 to mean target of $9.18, Based on 8 analyst forecasts
Low
$9.09
Median
$9.18
High
$9.45

Price Target Revisions

1 Month
63.64%
3 Months
63.64%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for ITRM. The average price target is 9.18 USD. This implies a price increase of 25686.52% is expected in the next year compared to the current price of 0.0356.
The average price target has been revised upward by 63.64% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ITRM Current Analyst RatingITRM Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

ITRM Historical Analyst RatingsITRM Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.50%
ITRM was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ITRM.
In the previous month the buy percentage consensus was at a similar level.
ITRM was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2024-09-10HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-15HC Wainwright & Co.Maintains Buy -> Buy
2024-06-21HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-31HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-14HC Wainwright & Co.Reiterate Buy -> Buy
2024-04-30HC Wainwright & Co.Reiterate Buy -> Buy
2024-04-01HC Wainwright & Co.Reiterate Buy -> Buy
2024-03-06HC Wainwright & Co.Reiterate Buy -> Buy
2024-02-07HC Wainwright & Co.Upgrade Neutral -> Buy
2021-07-27Gabelli & Co.Upgrade Sell -> Hold
2021-07-26HC Wainwright & Co.Downgrade Buy -> Neutral
2021-05-28Gabelli & Co.Upgrade Sell -> Hold
2021-03-15HC Wainwright & Co.Upgrade Neutral -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 11, 2026
Period
Q4 / 2025
EPS Estimate
-$0.15
Revenue Estimate
515.1K
Revenue Q2Q
N/A
EPS Q2Q
35.70%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
-83.19%
EPS (1 Month)
0.00%
EPS (3 Months)
-52.63%

Next Earnings Summary

ITRM is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -0.15 USD and the consensus revenue estimate is 515.10K USD.
The next earnings revenue estimate has been revised downward by 83.19% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2025 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ITRM revenue by date.ITRM revenue by date.
510K870K
70.59%		40K
-95.40%
-100.00%		912.9K9.564M
947.65%		42.172M
340.95%		49.708M
17.87%		77.684M
56.28%		163.95M
111.05%		201.85M
23.12%		240.31M
19.05%		316.98M
31.90%
EBITDA
YoY % growth
ITRM ebitda by date.ITRM ebitda by date.
-29.39M
-119.99%		-76.42M
-160.02%		-101.87M
-33.30%		-34.986M
68.63%		N/A
29.79%		N/A
-27.36%		N/A
-58.33%		N/A
58.64%		-25.602M
-36.79%		-16.524M
35.46%		25.398M
253.70%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ITRM ebit by date.ITRM ebit by date.
-29.46M
-120.51%		-76.56M
-159.88%		-102.02M
-33.25%		-35.463M
68.52%		-24.692M
23.60%		-41.231M
-23.80%		-48.998M
-54.71%		-20.606M
59.57%		-23.438M
-23.36%		-17.717M
24.41%		2.008M
111.33%		-9.704M
-583.28%		7.599M
178.31%		68.253M
798.18%		93.395M
36.84%		116.81M
25.07%		171.86M
47.13%
Operating Margin
ITRM operating margin by date.ITRM operating margin by date.
-5,776.47%-8,800.00%-255,050.00%N/AN/AN/AN/AN/A-2,567.37%-185.25%4.76%-19.52%9.78%41.63%46.27%48.61%54.22%
EPS
YoY % growth
ITRM eps by date.ITRM eps by date.
N/AN/A-106.65
26.89%		-37.28
63.85%		-8.72
70.04%		-3.06
80.26%		-3.01
-32.20%		-1.19
57.20%		-0.67
47.81%		-0.32
53.03%		0.06
117.74%		0.22
300.00%		1.17
422.73%		N/AN/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.15
35.70%		-0.10
27.14%		-0.10
36.25%		-0.09
54.10%		-0.09
37.93%
Revenue
Q2Q % growth		515.1K1.428M1.965M2.41M
517.95%		3.124M
506.48%
EBITDA
Q2Q % growth		-8.262M
-144.00%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-4.32M
-17.70%		-4.787M
-29.03%		-4.663M
15.65%		-4.854M
37.21%		-4.606M
-6.64%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ITRM Yearly Revenue VS EstimatesITRM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M
ITRM Yearly EPS VS EstimatesITRM Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 -50 -100

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
26.90%
EPS Next 5 Year
23.81%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
47.86%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ITERUM THERAPEUTICS PLC / ITRM Forecast FAQ

What is the average price target for ITERUM THERAPEUTICS PLC (ITRM) stock?

8 analysts have analysed ITRM and the average price target is 9.18 USD. This implies a price increase of 25686.52% is expected in the next year compared to the current price of 0.0356.

What is the next earnings date for ITRM stock?

ITERUM THERAPEUTICS PLC (ITRM) will report earnings on 2026-05-11.

What are the consensus estimates for ITRM stock next earnings?

The consensus EPS estimate for the next earnings of ITERUM THERAPEUTICS PLC (ITRM) is -0.15 USD and the consensus revenue estimate is 515.10K USD.

How many analysts have analysed ITERUM THERAPEUTICS PLC (ITRM)?

The number of analysts covering ITERUM THERAPEUTICS PLC (ITRM) is 8.